Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2020 Nov 5;55(2):462. doi: 10.1007/s43441-020-00238-9

Correction to: Patient Contribution to the Development and Safe Use of Medicines During the Covid-19 Pandemic

Peter J Pitts 1,, François Houÿez 2
PMCID: PMC7643522  PMID: 33151501

Correction to: Therapeutic Innovation & Regulatory Science 10.1007/s43441-020-00235-y

There is a typographical error in the original article’s Acknowledgements section. The corrected version follows:

Acknowledgements

The authors submit this report based on the work of the CIOMS WG XI, focusing on patient involvement in the development and safe use of medicines, CIOMS has been working diligently with patient organisations, academia, pharmaceutical industry, and health authorities to help address the questions raised in this Statement and other issues. The CIOMS WG XI report is expected to be published in 2021. CIOMS Working Group WG XI: Patient involvement in the development and safe use of medicines. For more information about the Working Group and its members, please visit: https://cioms.ch/working-groups/working-group-xi-patient-involvement/.


Articles from Therapeutic Innovation & Regulatory Science are provided here courtesy of Nature Publishing Group

RESOURCES